These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28820006)

  • 1. An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats.
    Ma JY; Snook S; Garrovillo S; Johnson C; La D
    Int J Toxicol; 2017; 36(5):386-394. PubMed ID: 28820006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
    Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
    Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats.
    Obert LA; Sobocinski GP; Bobrowski WF; Metz AL; Rolsma MD; Altrogge DM; Dunstan RW
    Toxicol Pathol; 2007 Aug; 35(5):728-34. PubMed ID: 17763287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis.
    Sakurai T; Kamio K; Sasaki K; Nishimoto T; Yamaguchi JI; Sasaki M; Tsutsumi S
    Am J Pathol; 2018 Sep; 188(9):1993-2003. PubMed ID: 29981744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Paraphenylenediamine Staining for Assessment of Phospholipidosis.
    Shirai N; Geoly FJ; Bobrowski WF; Okerberg C
    Toxicol Pathol; 2016 Dec; 44(8):1160-1165. PubMed ID: 27770109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA; Bendayan M
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
    Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and tissue indicators of para-aminophenol nephrotoxicity in sprague-dawley rats.
    Yang A; Trajkovic D; Illanes O; Ramiro-Ibáñez F
    Toxicol Pathol; 2007 Jun; 35(4):521-32. PubMed ID: 17562485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity.
    Laurent G; Kishore BK; Tulkens PM
    Biochem Pharmacol; 1990 Dec; 40(11):2383-92. PubMed ID: 2268362
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
    Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
    Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864.
    Rudmann DG; McNerney ME; VanderEide SL; Schemmer JK; Eversole RR; Vonderfecht SL
    Toxicol Pathol; 2004; 32(3):326-32. PubMed ID: 15204974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gentamicin-induced nephrotoxicity by lithium in rat.
    Samadian T; Dehpour AR; Amini S; Nouhnejad P
    Histol Histopathol; 1993 Jan; 8(1):139-47. PubMed ID: 8443425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of phospholipidosis induction: a cell-based assay in high-throughput and high-content format.
    Shahane SA; Huang R; Gerhold D; Baxa U; Austin CP; Xia M
    J Biomol Screen; 2014 Jan; 19(1):66-76. PubMed ID: 24003057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.
    Ploemen JP; Kelder J; Hafmans T; van de Sandt H; van Burgsteden JA; Saleminki PJ; van Esch E
    Exp Toxicol Pathol; 2004 Mar; 55(5):347-55. PubMed ID: 15088636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique renal tubule changes induced in rats and mice by the peroxisome proliferators 2,4-dichlorophenoxyacetic acid (2,4-D) and WY-14643.
    Ozaki K; Mahler JF; Haseman JK; Moomaw CR; Nicolette ML; Nyska A
    Toxicol Pathol; 2001; 29(4):440-50. PubMed ID: 11560249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.
    Feldman S; Wang MY; Kaloyanides GJ
    J Pharmacol Exp Ther; 1982 Mar; 220(3):514-20. PubMed ID: 7062263
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression and mechanism of osteoactivin in the kidney of SD rats after acute cyclosporine A toxicity].
    Ye M; Xie X; Peng L; Tan L; Lan G; Yu S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):881-8. PubMed ID: 21946207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease.
    Guigui B; Perrot S; Berry JP; Fleury-Feith J; Martin N; Métreau JM; Dhumeaux D; Zafrani ES
    Hepatology; 1988; 8(5):1063-8. PubMed ID: 3417226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.